Expert Interview
Discussing Simcere Pharmaceuticals' Group SIM0500, a humanized GPRC5D-BCMA-CD3 trispecific antibody, in participants with relapsed or refractory multiple myeloma.
Ticker(s): ABBVInstitution: Washington University St. Louis
- Professor Department of Medicine Oncology Division Bone Marrow Transplantation & Leukemia.
- Currently treats ~300 patients with multiple myeloma (total)
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
